Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging comparison with positron emission tomography

Circulation

Volumn 105, Issue 2, 2002, Pages 162-167

  Klein, Christoph ^a   Nekolla, Stephan G ^a   Bengel, Frank M ^a   Momose, Mitsuru ^a   Sammer, Andrea ^a   Haas, Felix ^a   Schnackenburg, Bernhard ^a   Delius, Wolfram ^a   Mudra, Harald ^a   Wolfram, Dieter ^a   Schwaiger, Markus ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Coronary disease; Heart failure; Hibernation; Magnetic resonance

Indexed keywords

GADOLINIUM PENTETATE;

ADULT; AGED; ARTICLE; BOLUS INJECTION; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DISEASE SEVERITY; FEMALE; GLUCOSE METABOLISM; HEART EJECTION FRACTION; HEART FAILURE; HEART INFARCTION SIZE; HEART MUSCLE METABOLISM; HEART MUSCLE PERFUSION; HUMAN; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; SCAR; SENSITIVITY AND SPECIFICITY; STANDARD;

CELL SURVIVAL; CONTRAST MEDIA; CORONARY DISEASE; GADOLINIUM DTPA; HEART FAILURE, CONGESTIVE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIUM; REFERENCE STANDARDS; ROC CURVE; SENSITIVITY AND SPECIFICITY; STROKE VOLUME; TOMOGRAPHY, EMISSION-COMPUTED; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0037080527     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/hc0202.102123     Document Type: Article

References (26)

1. The hibernating myocardium
2. A randomized trial of coronary artery bypass surgery: Survival of patients with a low ejection fraction
3. Hibernating myocardium
4. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography
5. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy
6. Preoperative positron emission tomographic viability assessment and perioperative and postoperative risk in patients with advanced ischemic heart disease
7. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography
8. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function
9. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction
10. Myocardial glucose uptake in patients with insulin-dependent diabetes mellitus assessed quantitatively by dynamic positron emission tomography
11. Time course and extent of improvement of dysfunctioning myocardium in patients with coronary artery disease and severely depressed left ventricular function after revascularization: Correlation with positron emission tomographic findings
12. Reproducibility of polar map generation and assessment of defect severity and extent assessment in myocardial perfusion imaging using positron emission tomography
13. Regression analysis
14. Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: Comparison of pooled data
15. Positron emission tomography using fluorine-18 deoxyglucose in evaluation of coronary artery bypass grafting
16. There may be more to myocardial viability than meets the eye
17. 18fluorodeoxyglucose and 201TI in patients with chronic coronary artery disease and left ventricular dysfunction
18. Chronic myocardial infarction: Assessment of morphology, function, and perfusion by gradient echo magnetic resonance imaging and 99 mTc-methoxyisobutyl-isonitrile SPECT
19. Comparison of low-dose dobutamine-gradient-echo magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in patients with chronic coronary artery disease: A functional and morphological approach to the detection of residual myocardial viability
20. Contrast magnetic resonance imaging in the assessment of myocardial viability in patients with stable coronary artery disease and left ventricular dysfunction
21. Effect of gadolinium-DTPA on the magnetic relaxation times of normal and infarcted myocardium
22. Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction
23. Contrast-enhanced NMR imaging: Animal studies using gadolinium-DTPA complex
24. Histological alterations in chronically hypoperfused myocardium: Correlation with PET findings
25. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction: Role of magnetic resonance imaging
26. An improved MR imaging technique for the visualization of myocardial infarction